Advertisement
UK markets close in 8 hours 17 minutes
  • FTSE 100

    8,040.38
    0.00 (0.00%)
     
  • FTSE 250

    19,719.37
    0.00 (0.00%)
     
  • AIM

    754.69
    0.00 (0.00%)
     
  • GBP/EUR

    1.1658
    +0.0014 (+0.12%)
     
  • GBP/USD

    1.2491
    +0.0028 (+0.23%)
     
  • Bitcoin GBP

    51,481.87
    -2,000.03 (-3.74%)
     
  • CMC Crypto 200

    1,389.86
    +7.29 (+0.53%)
     
  • S&P 500

    5,071.63
    +1.08 (+0.02%)
     
  • DOW

    38,460.92
    -42.77 (-0.11%)
     
  • CRUDE OIL

    83.06
    +0.25 (+0.30%)
     
  • GOLD FUTURES

    2,333.50
    -4.90 (-0.21%)
     
  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     
  • HANG SENG

    17,289.13
    +87.86 (+0.51%)
     
  • DAX

    18,088.70
    -48.95 (-0.27%)
     
  • CAC 40

    8,091.86
    0.00 (0.00%)
     

Philips' Dual Use DRF System Gets FDA Nod for Marketing

Koninklijke Philips N.V. PHG has received approval of the U.S. Food and Drug Administration (FDA) to market its latest Digital Radiography-Fluoroscopy (DRF) system- ProxiDiagnost N90.

The company’s new two-in-one DRF system not only assists augmented patient throughput and high room utilization but also offers patient accessibility and extraordinary workflow support.  

ProxiDiagnost N90 is an appropriate gadget for modern healthcare organizations which require advanced fluoroscopy solutions, especially the U.S. companies that track a nearby use procedure.

ProxiDiagnost N90 produces premium quality images with the help of its new dynamic UNIQUE image processor and flat-detector technology. Moreover, the system permits technologies to conduct measures next to patient for enhancing patient experience. The system also includes the Philips Eleva user interface, enabling clinicians to utilize the system instantly without added training.

Also, ProxiDiagnost N90 has a small footprint and a unique design that includes an open overhead area and table, ensuring closer interaction between technologists and patients during procedures.

Poor Zacks Rank

Over the past year, Philips’ shares have rallied 24%, outperforming 16.6% growth recorded by the industry.

 

However, the stock currently carries a Zacks Rank #4 (Sell). The company believes its near-term profitability will be hurt due to sluggish growth rate of the global healthcare market. Additionally, high restructuring and acquisition-related costs, and macroeconomic challenges in some of its key markets might be concerns in the quarters ahead.

Stocks to Consider  

Some better-ranked stocks in the Zacks Computer and Technology sector are listed below:

Agilent Technologies, Inc. A carries a Zacks Rank of 2 (Buy). The company recorded a positive average earnings surprise of 13.6% in the last three to five quarters. You can see the complete list of today’s Zacks #1 (Strong Buy) Rank stocks here.

ACI Worldwide, Inc. ACIW also holds a Zacks Rank of 2. The company pulled off an outstanding average positive earnings surprise of 151.89% during the same time frame.

Adobe Systems Incorporated ADBE carries a Zacks Rank of 2. The company recorded an average positive earnings surprise of 9.03% over the last three to five quarters.

The Hottest Tech Mega-Trend of All                 

Last year, it generated $8 billion in global revenues. By 2020, it's predicted to blast through the roof to $47 billion. Famed investor Mark Cuban says it will produce ""the world's first trillionaires,"" but that should still leave plenty of money for regular investors who make the right trades early.

See Zacks' 3 Best Stocks to Play This Trend >>              


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Adobe Systems Incorporated (ADBE) : Free Stock Analysis Report
 
ACI Worldwide, Inc. (ACIW) : Free Stock Analysis Report
 
Koninklijke Philips N.V. (PHG) : Free Stock Analysis Report
 
Agilent Technologies, Inc. (A) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research